About Keith Valentine
Keith Valentine is a director at Regentis Biomaterials.
Form D filings name Keith Valentine as a director at Reiley Pharmaceuticals.
Keith Valentine reports to the SEC as a director or officer of 6 public companies, including Alphatec (ATEC), Si-Bone (SIBN) and Orthofix Medical (OFIX).
Keith Valentine first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Keith Valentine in the role, so the role may have started earlier or lasted longer.
RL
Regentis Biomaterials Ltd.
Director
2026 · Public company (RGNT)
AI
Alphatec Holdings, Inc.
Director
2024 – 2026 · Public company (ATEC)
SI
Si-Bone, Inc.
Director
2018 – 2023 · Public company (SIBN)
OI
Orthofix Medical Inc.
President & CEO, director
2023 · Public company (OFIX)
SC
SeaSpine Holdings Corp
Chief Executive Officer and director
2015 – 2023 · Public company (SPNE)
NI
Nuvasive Inc.
COO
2006 – 2015 · Public company (NUVA)
Key Colleagues at Startups
The people Keith Valentine works with at each company, as listed on that company's latest Form D.
Reiley Pharmaceuticals, Inc. · Form D, Jun 5, 2024